Georgios Tsivgoulis
Georgios Tsivgoulis is an expert in Neurology at University General Hospital Attikon (Greece). As of October 2026, ScienceLeadR ranks Georgios Tsivgoulis in the top 1% of experts worldwide for Cerebrovascular Disorders, Brain Ischemia and Cerebral Hemorrhage. Georgios Tsivgoulis has authored 1,114 publications, the most recent in 2026, and is an investigator in 40 clinical trials, 16 of them ongoing. SLR score: 4,732 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Cardiology - Public Health - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2004 - 2026
Number : 1114
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| FXIa inhibitors and secondary stroke prevention. PMID 42929312 — anticoagulants, hemorrhage, ischemic stroke, stroke, atrial fibrillation, therapeutics, nervous system diseases | Curr Opin Neurol | 2026 | 0 |
| Beyond the Threshold: Continuous Creatinine Change and Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke. PMID 42817886 — creatinine, mortality, ischemic stroke, stroke, hospital mortality, odds ratio, cerebrovascular disorders, thrombectomy, acute kidney injury, prognosis, endovascular procedures | Stroke | 2026 | 0 |
| Non-contrast CT Markers of Hematoma Expansion and Andexanet Response in Factor Xa Inhibitor-Associated Intracerebral Hemorrhage: An Analysis from ANNEXa-I Trial. PMID 42708556 — cerebral hemorrhage, hemorrhage, hematoma, antithrombin iii, factor xa inhibitors, factor xa | Ann Neurol | 2026 | 0 |
| Bleeding With Asundexian Versus Placebo in Patients With Noncardioembolic Ischemic Stroke or High-Risk TIA: OCEANIC-STROKE Randomized Trial. PMID 42866879 — hemorrhage, ischemic stroke, stroke, cardiovascular system, therapeutics, blood circulation | Circulation Top journal | 2026 | 0 |
| Factor XIa Inhibitors for Secondary Prevention After Noncardioembolic Stroke: A Systematic Review and Meta-Analysis. PMID 42748394 — hemorrhage, ischemic stroke, stroke, secondary prevention, factor xia, therapeutics, neurology, factor xia inhibitor | Neurology | 2026 | 0 |
Clinical Studies 40
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 4
Ongoing Clinical Trials
16 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A study to assess the long term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with active idiopathic inflammatory myopathy 2022-502851-79-00 — muscular diseases, safety, aged, myositis | Phase 3 | Active not recruiting | 2023 |
| A study to test if tenecteplase helps people to recover from an acute stroke when given more than 4 5 hours after the person was last seen well 2025-522542-40-00 — safety, ischemic stroke, stroke, tenecteplase, tissues | Phase 3 | Recruiting | 2026 |
| A study to investigate long term safety and tolerability of tolebrutinib in participants with multiple sclerosis 2023-503631-18-01 — sclerosis, multiple sclerosis, safety, nervous system, nervous system diseases, primary progressive multiple sclerosis, secondary progressive multiple sclerosis | Phase 3 | Active not recruiting | 2024 |
| A Phase 3 Placebo controlled Study of Milvexian after an Acute Ischemic Stroke or High Risk Transient Ischemic Attack 2022-501176-26-00 — safety, ischemic stroke, stroke, ischemic attack, transient, factor xia, factor xia inhibitor | Phase 3 | Active not recruiting | 2023 |
| A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT KarX EC for the Treatment of Agitation Associated with Alzheimer s Disease 2025-520613-31-00 — safety, alzheimer disease, therapeutics | Phase 3 | Recruiting | 2025 |
LeadR Networks
Main global connection map